In this year’s study carried out by the FAZ Institute in cooperation with the Institute for Management and Economic Research as well as scientific associate Prognos, ulrich medical has been named one of Germany’s innovation leaders for the year 2020. The comparison is based on an international patent analysis over the last ten years.
A total of 150,000 German companies were considered to determine their innovative strength, including patents from ulrich’s product areas of contrast media injectors and spinal implants.
Chief executive officer Klaus Kiesel said: “Now that our achievements have been recognised, this shows us that our consistent focus on developing future-oriented technologies and products that live up to the ‘made in Germany’ quality is exactly on point.”
Managing partner Christoph Ulrich (right) added: “This secures our sustainable and successful growth in the long term and also strengthens confidence in ulrich medical as a strong partner and attractive employer.”
Picture: ulrich medical chief executive officer Klaus Kiesel and managing partner Christoph Ulrich.
Published on page 4 of the September 2020 issue of RAD Magazine.